The government has allowed another vaccine against Covid-19 under “emergency use authorisation” and given a go-ahead to a local pharmaceutical company for the import and distribution of the Russian-developed Sputnik V.
With the fresh decision, the official said, Russia’s Sputnik V Covid-19 vaccine became the third to be approved for emergency use in the country.
“In a meeting conducted by the registration board of the Drug Regulatory Authority of Pakistan (Drap), another vaccine has also been given EUA (emergency use authorisation) which was developed with the backing of Russian Development Investment Fund,” the official privy to the development said.
Last week, Drap authorised the Oxford University-AstraZeneca Covid-19 vaccine for emergency use in Pakistan. A couple of days later, the regulatory body approved Chinese state-owned firm Sinopharm’s Covid-19 vaccine for emergency use, the second shot to be given approval for use in the country.
“Sputnik V is the world’s first registered vaccine based on a well-studied human adenoviral vector-based platform,” said the information available on the Sputnik V website. “It currently ranks among top-10 candidate vaccines approaching the end of clinical trials and the start of mass production on the World Health Organisation’s (WHO) list.”
The ongoing Sputnik V post-registration clinical trial in Russia involved 40,000 volunteers, it said and added that clinical trials of Sputnik V had been announced in the UAE, India, Venezuela and Belarus.
Last week, Hungary became the first European Union country to approve the Sputnik V coronavirus vaccine for public distribution. A short time later the UAE also announced the same decision making it 12th country outside of Russia which have authorised its use.